Safety and immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (Inactivated) (JEBIK®V) in children

MLA

Okada, Kenji, et al. “Safety and Immunogenicity of a Freeze-Dried, Cell Culture-Derived Japanese Encephalitis Vaccine (Inactivated) (JEBIK®V) in Children.” Vaccine, vol. 30, no. 41, Sept. 2012, pp. 5967–72. EBSCOhost, https://doi.org/10.1016/j.vaccine.2012.07.034.

APA

Okada, K., Iwasa, T., Namazue, J., Akechi, M., & Ueda, S. (2012). Safety and immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (Inactivated) (JEBIK®V) in children. Vaccine, 30(41), 5967–5972. https://doi.org/10.1016/j.vaccine.2012.07.034

Chicago

Okada, Kenji, Toshiaki Iwasa, Junko Namazue, Masateru Akechi, and Shigeharu Ueda. 2012. “Safety and Immunogenicity of a Freeze-Dried, Cell Culture-Derived Japanese Encephalitis Vaccine (Inactivated) (JEBIK®V) in Children.” Vaccine 30 (41): 5967–72. doi:10.1016/j.vaccine.2012.07.034.